ArticleToxins2025
Rapid Detection of Saxitoxin Using a Nucleic Acid Aptamer Biosensor Based on Graphene Oxide as a Fluorescence Quencher.
Article in Toxins, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A Robust Electrochemical Aptasensor Based on a AuNP/Chitosan Conductive Network for Saxitoxin Detection in Freshwater Samples.Biosensors · 2026Article
- Aptamer-Based Fluorescent Biosensors for Kanamycin Detection in Food Systems: Design Strategies, Sensing Mechanisms, and Practical Applications.Foods (Basel, Switzerland) · 2026Review
- Nanotechnological applications of marine algae derived neurotoxins spanning harmful algal blooms and therapeutic innovations.Discover nano · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Saxitoxin (STX) is a toxin with paralyzing and lethal properties, necessitating the development of a simple analytical method. This study developed a nucleic acid aptamer biosensor using graphene oxide (GO) as a fluorescence quencher for STX detection. GO was combined with M30-f, an STX nucleic acid aptamer modification with 5-carboxyfluorescein, which can produce fluorescence absorption under the conditions of an excitation wavelength of 408 nm and emission wavelength of 515 nm. Based on the principle of fluorescence resonance energy transfer, the fluorescence of M30-f was quenched. In the presence of STX, M30-f specifically binds to STX and dissociates from the GO surface, thereby restoring fluorescence. The STX content can be quantitatively detected through differences in fluorescence absorption. The influence of ultrasonic time on the fluorescence quenching ability of GO was investigated. The aqueous solution of graphene oxide, 30GO, optimized by ultrasound treatment for a duration of 30 min, demonstrated excellent fluorescence quenching capability. 30GO was analyzed utilizing various characterization techniques, including SEM, FT-IR, UV, XPS, XRD, AFM, and contact angle measurements. The methodological validation showed that the established STX sensor exhibits excellent linearity within a concentration range of 10-100,000 ng/L, with a limit of detection (LOD) as low as 0.098 μg/L. In addition, the results further demonstrated the sensor's high specificity for detecting neurotoxic shellfish toxin STX. The recovery rate for clam samples ranged from 89.12% to 104.71%, while that for oyster samples ranged from 91.20% to 109.65%, with relative standard deviations (RSDs) all below 3%. This aptamer sensor is characterized by its simplicity, high sensitivity, and broad detection range, providing significant technical support for advancing marine biotoxin research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.